Insider · CIK 0001741287

DAVIS JOHN C. JR

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001741287

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-11	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	See Remarks	AAward	+72.5K sh	—	—	72,500
2020-04-14	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	See Remarks	AAward	+50K sh	—	—	50,000
2020-02-10	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	See Remarks	AAward	+104K sh	—	—	104,000
2020-01-02	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	See Remarks	MExercise/Conversion	+11.3K sh	$9.49	+$107K	19,598
2020-01-02	DNTHDianthus Therapeutics, Inc. /DE/S Sale	See Remarks	SSale	−11.3K sh	$15.04	−$170K	8,304
2020-01-02	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−11.3K sh	—	—	224,831
2019-12-20	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	See Remarks	MExercise/Conversion	+114 sh	$9.49	+$1,081.86	8,418
2019-12-20	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	See Remarks	MExercise/Conversion	+805 sh	$9.49	+$7,639.45	9,223
2019-12-20	DNTHDianthus Therapeutics, Inc. /DE/S Sale	See Remarks	SSale	−919 sh	$15.00	−$13.8K	8,304
2019-12-20	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−805 sh	—	—	236,239
2019-12-20	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−114 sh	—	—	236,125
2019-12-10	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	See Remarks	MExercise/Conversion	+17.1K sh	$9.49	+$162K	25,359
2019-12-10	DNTHDianthus Therapeutics, Inc. /DE/S Sale	See Remarks	SSale	−17.1K sh	$15.00	−$256K	8,304
2019-12-10	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−17.1K sh	—	—	237,044
2019-12-09	DNTHDianthus Therapeutics, Inc. /DE/M Exercise/Conversion	See Remarks	MExercise/Conversion	+4,614 sh	$9.49	+$43.8K	12,918
2019-12-09	DNTHDianthus Therapeutics, Inc. /DE/S Sale	See Remarks	SSale	−4,614 sh	$15.00	−$69.2K	8,304
2019-12-09	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−4,614 sh	—	—	254,099
2019-02-05	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	See Remarks	AAward	+70K sh	—	—	70,000
2018-06-25	DNTHDianthus Therapeutics, Inc. /DE/C Conversion	See Remarks	CConversion	+8,304 sh	—	—	8,304
2018-06-25	DNTHDianthus Therapeutics, Inc. /DE/ · Series C Preferred StockC Conversion	See Remarks	CConversion	−21.5K sh	—	—	0

Recent filings

Accepted (ET)
Feb 164
DAVIS JOHN C. JR0000899243-21-006715
SEC(opens sec.gov)
Apr 164
DAVIS JOHN C. JR0000899243-20-010847
SEC(opens sec.gov)
Feb 124
DAVIS JOHN C. JR0000899243-20-004321
SEC(opens sec.gov)
Jan 34
DAVIS JOHN C. JR0001562180-20-000119
SEC(opens sec.gov)
Dec 204
DAVIS JOHN C. JR0001562180-19-006220
SEC(opens sec.gov)
Dec 114
DAVIS JOHN C. JR0001562180-19-006009
SEC(opens sec.gov)
Feb 74
DAVIS JOHN C. JR0000899243-19-002872
SEC(opens sec.gov)
Jun 274
DAVIS JOHN C. JR0000899243-18-018317
SEC(opens sec.gov)

Companies

Dianthus Therapeutics, Inc. /DE/See RemarksDNTH

Address

C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139